{"id":7121,"date":"2019-12-16T15:52:24","date_gmt":"2019-12-16T10:22:24","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=7121"},"modified":"2025-05-08T12:57:06","modified_gmt":"2025-05-08T07:27:06","slug":"bipolar-disorder-market","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market","title":{"rendered":"Increasing cases of Mania and Bipolar disorder market"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-6a0df3a78fca6\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-6a0df3a78fca6\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market\/#Bipolar_disorder_Epidemiology\" >Bipolar disorder Epidemiology<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market\/#Bipolar_disorder_Treatment_Market\" >Bipolar disorder Treatment Market<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market\/#Pharmacologic_treatments\" >Pharmacologic treatments<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market\/#Psychotherapy\" >Psychotherapy<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market\/#Bipolar_disorder_market\" >Bipolar disorder market<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n\n<p class=\"has-drop-cap\"><strong>Bipolar Disorder<\/strong> is characterized by frequent-shifts in the mood and is a manic-depressive disorder hampering the routine life of an individual. <br>According to the <strong>American Psychiatric Association<\/strong>, there are four major types of bipolar disorder: Bipolar I disorder, Bipolar II disorder, Cyclothymic disorder, and Bipolar disorder due to another medical or substance abuse disorder.<\/p>\n\n\n\n<p>However, all of these types involve fluctuations in mood and energy levels, but they differ in their phases of the depression (extremely disheartened, low) and manic (extremely energized, up) caused.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-bipolar-disorder-epidemiology\"><span class=\"ez-toc-section\" id=\"Bipolar_disorder_Epidemiology\"><\/span><strong>Bipolar disorder Epidemiology <\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>As per National Alliance on Mental Illness (NAMI), Bi-polar disorder\nequally affects men and women. <\/p>\n\n\n\n<p>As per a study conducted by Vos et al., Bipolar disorder was labeled as\nthe 18<sup>th<\/sup> most prevalent debilitating and disabling disorder in the\nworld. <\/p>\n\n\n\n<p><strong>According to a study, an estimated 2.9 percent of all the Americans are diagnosed with Bipolar disorder and out of which 83 percent of the cases are categorized under severe. <\/strong><\/p>\n\n\n\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/bipolar-disorder-manic-depression-epidemiology-forecast\">Bipolar disorder prevalence<\/a> in the US is about 2.8 percent. Approximately 83% of cases of bipolar disorder are classified as &#8220;severe&#8221;. <\/p>\n\n\n\n<p>According to a study \u201cBipolar disorders\u201d conducted by Eduard Vieta et al., the estimated lifetime Bipolar disorder I prevalence is 0.6%, and it is 0.4% for bipolar II disorder. The prevalence is 1.4% for sub-threshold manifestations of bipolar disorders and 2.4% for the broader spectrum of bipolar disorders. <\/p>\n\n\n\n<p>Community-based epidemiological studies reported by the National Institute for Health and Care Excellence states that lifetime prevalence rates in Europe vary from 0.1% to 2.4%\u201d<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-bipolar-disorder-treatment-market\"><span class=\"ez-toc-section\" id=\"Bipolar_disorder_Treatment_Market\"><\/span><strong>Bipolar disorder Treatment Market <\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"has-very-dark-gray-color has-text-color has-background\" style=\"background-color:#e2c9e6\"><strong>The origin of Bi-polar disorder is still uncertain. <\/strong><\/p>\n\n\n\n<p>The etiology of the disorder is still not fully understood. However,\nresearch in an attempt to disclose the underlying root cause of the disease is\ngoing on. The research in the last decade points out various factors including\ngenetic makeup of any individual, progression of the disease, and certain\ngene-environment interactions.<\/p>\n\n\n\n<p>Bipolar disorder is a multifactorial illness involving episodes of\nsevere mood disturbance, neuropsychological deficits, immunological and\nphysiological changes, and disturbances in functioning.<\/p>\n\n\n\n<p>Bipolar disorder treatment includes medication, psychotherapy, education, and self-management strategies. External supports from family, friends and support groups are also much required by Bipolar disorder patients.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-pharmacologic-treatments\"><span class=\"ez-toc-section\" id=\"Pharmacologic_treatments\"><\/span><strong>Pharmacologic treatments <\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Medications are an important part of treating Bipolar disorder. The conventional Bipolar disorder medications include mood stabilizers (e.g., lithium, valproate, lamotrigine, and carbamazepine), atypical antipsychotics, and antidepressants. <\/p>\n\n\n\n<p>Pharmacologic Bipolar disorder medications are taken on a regular basis.<\/p>\n\n\n\n<p>The Bipolar disorder treatment market includes FDA-approved drugs such as lithium, lamotrigine, valproate, carbamazepine, and most atypical antipsychotic medications, as per the American Psychiatric Association (APA).<\/p>\n\n\n\n<p>The first to gain approval from the US FDA, Lithium so far remains the most effective medicine for the prevention of acute mania in the Bipolar treatment market. Similarly, Valproate, a mood-stabilized, also prevents manic fits and works in the brain tissues. <\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-psychotherapy\"><span class=\"ez-toc-section\" id=\"Psychotherapy\"><\/span><strong>Psychotherapy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p><strong>Psychotherapy<\/strong> is also an important part of the Bipolar disorder treatment process. It involves cognitive behavioral therapy and family-focused therapies that help the Bipolar patients and their care-takers to cope up with the negative, and depressive feelings. <\/p>\n\n\n\n<p><strong>Olanzapine-fluoxetine<\/strong> combination, <strong>Lurasidone,<\/strong> and <strong>Quetiapine<\/strong> are the three FDA-approved agents for effective Bipolar disorder treatment. <\/p>\n\n\n\n<p><strong>Olanzapine-fluoxetine<\/strong> combination is the only FDA-approved antidepressant for treating depressions associated with Bipolar disorder. This is due to the controversy that remains about the use of antidepressant drugs in managing depressive episodes. <\/p>\n\n\n\n<p>Few of the therapies that recently entered the <strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/bipolar-disorder-manic-depression-market\" class=\"ek-link\">Bipolar disorder market<\/a><\/strong> are <strong>Licarbazepine<\/strong> (Novartis), <strong>FK949E<\/strong> (Astellas Pharma), <strong>Asenapine<\/strong> (Merck), <strong>ziprasidone<\/strong> (Pfizer), <strong>Aripiprazole<\/strong> (Bristol-Myers Squibb\/Otsuka Pharmaceutical) and <strong>Risperidone<\/strong> (Janssen).<\/p>\n\n\n\n<p>Several <strong>off-label drugs<\/strong> are also administered to Bipolar disorder patients since they were able to perform better during the trials in reducing the intensity of the depressions. These include <strong>anticonvulsants<\/strong> (such as Divalproex and lamotrigine), <strong>olanzapine<\/strong> <strong>monotherapy<\/strong> and combined lithium and <strong>lamotrigine<\/strong> therapy make treatment of bipolar disorder complex, including the fluctuation of mood episodes and the effects of these episodes on patient well-being, treatment nonadherence, side effects to drugs, and comorbid psychiatric disorders. Improved understanding of the mechanisms underlying the regulation of emotions, maturation and brain function in healthy individuals will help to identify specific circuits and pathways as targets for novel therapeutic approaches.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-bipolar-disorder-market\"><span class=\"ez-toc-section\" id=\"Bipolar_disorder_market\"><\/span><strong>Bipolar disorder market <\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>The <strong>Bipolar disorder market size<\/strong> is expected to increase during\nthe forecast period of [2019\u20132028]. The major <strong>Bipolar disorder market\ndrivers<\/strong> such as increasing prevalent population, acceptance of the patients\nin the society, technological advancements and a strong Bipolar disorder\ntherapies are anticipated to steer the Bipolar disorder market in forward\ndirection.<\/p>\n\n\n\n<p>The <strong>Bipolar Disorder market dynamics<\/strong> are anticipated to change during the forecasted period owing to the expected launch of emerging therapies during the forecast period. <\/p>\n\n\n\n<p>Current Bipolar disorder treatments are still at the na\u00efve stage. Insufficiency and lack of substantial <a href=\"https:\/\/www.delveinsight.com\/report-store\/bipolar-disorder-manic-depression-pipeline-insight\">Bipolar disorder therapies<\/a>, and delayed onset of action are the current unmet needs in the Bipolar disorder market. This leads to relapses of Bipolar disorder in the patients leading to disability. However, Key pharma players such as <strong>Lundbeck<\/strong>, <strong>Otsuka Pharmaceutica<\/strong>l, <strong>Intra<\/strong>&#8211;<strong>Cellular<\/strong> <strong>Therapies<\/strong>, and <strong>Sage<\/strong> <strong>Therapeutics<\/strong> have products in the pipeline with the aim to target novel therapeutic targets effectively.<\/p>\n\n\n\n<p>Recent decades have also observed major advancements in the <a href=\"https:\/\/www.delveinsight.com\/report-store\/bipolar-disorder-manic-depression-global-api-manufacturers-marketed-and-phase-iii-drugs-landscape\">Bipolar disorder treatment market<\/a> with a reduction in the relapsing of the disorder. The governments of several nations are also allocating funds to advance the Bipolar disorder market size. <\/p>\n\n\n<p><!--EndFragment--><\/p>","protected":false},"excerpt":{"rendered":"<p>Bipolar Disorder is characterized by frequent-shifts in the mood and is a manic-depressive disorder hampering the routine life of an individual. According to the American Psychiatric Association, there are four major types of bipolar disorder: Bipolar I disorder, Bipolar II disorder, Cyclothymic disorder, and Bipolar disorder due to another medical or substance abuse disorder. However, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":7122,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17,17434],"tags":[7335,17898,7336,7338,7337,17899,1544,1736,2100],"industry":[17225],"therapeutic_areas":[17245],"class_list":["post-7121","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-facts-and-figures","tag-bipolar-disorder","tag-bipolar-disorder-epidemiology","tag-bipolar-disorder-market","tag-bipolar-disorder-pipeline","tag-bipolar-disorder-treatment-market","tag-intra-cellular-therapies","tag-lundbeck","tag-otsuka-pharmaceutical","tag-sage-therapeutics","industry-pharmaceutical","therapeutic_areas-neurology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Increasing cases of Mania and Bipolar disorder market -<\/title>\n<meta name=\"description\" content=\"The Bipolar disorder market size is expected to increase during the forecast period of [2019\u20132028]. The major Bipolar disorder market drivers such as...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Increasing cases of Mania and Bipolar disorder market -\" \/>\n<meta property=\"og:description\" content=\"The Bipolar disorder market size is expected to increase during the forecast period of [2019\u20132028]. The major Bipolar disorder market drivers such as...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-12-16T10:22:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-08T07:27:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/12\/16154620\/increasing-case-of-mania.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"772\" \/>\n\t<meta property=\"og:image:height\" content=\"482\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Increasing cases of Mania and Bipolar disorder market -","description":"The Bipolar disorder market size is expected to increase during the forecast period of [2019\u20132028]. The major Bipolar disorder market drivers such as...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market","og_locale":"en_US","og_type":"article","og_title":"Increasing cases of Mania and Bipolar disorder market -","og_description":"The Bipolar disorder market size is expected to increase during the forecast period of [2019\u20132028]. The major Bipolar disorder market drivers such as...","og_url":"https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2019-12-16T10:22:24+00:00","article_modified_time":"2025-05-08T07:27:06+00:00","og_image":[{"width":772,"height":482,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/12\/16154620\/increasing-case-of-mania.jpg","type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market","url":"https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market","name":"Increasing cases of Mania and Bipolar disorder market -","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/12\/16154620\/increasing-case-of-mania.jpg","datePublished":"2019-12-16T10:22:24+00:00","dateModified":"2025-05-08T07:27:06+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"The Bipolar disorder market size is expected to increase during the forecast period of [2019\u20132028]. The major Bipolar disorder market drivers such as...","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/12\/16154620\/increasing-case-of-mania.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/12\/16154620\/increasing-case-of-mania.jpg","width":772,"height":482,"caption":"Bipolar disorder market"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/12\/16154620\/increasing-case-of-mania-300x187.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Facts and Figures<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>","<span class=\"advgb-post-tax-term\">Facts and Figures<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Bipolar disorder<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Bipolar disorder Epidemiology<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Bipolar disorder market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Bipolar disorder pipeline<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Bipolar disorder treatment market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Intra Cellular Therapies<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Lundbeck<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Otsuka Pharmaceutical<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Sage Therapeutics<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Bipolar disorder<\/span>","<span class=\"advgb-post-tax-term\">Bipolar disorder Epidemiology<\/span>","<span class=\"advgb-post-tax-term\">Bipolar disorder market<\/span>","<span class=\"advgb-post-tax-term\">Bipolar disorder pipeline<\/span>","<span class=\"advgb-post-tax-term\">Bipolar disorder treatment market<\/span>","<span class=\"advgb-post-tax-term\">Intra Cellular Therapies<\/span>","<span class=\"advgb-post-tax-term\">Lundbeck<\/span>","<span class=\"advgb-post-tax-term\">Otsuka Pharmaceutical<\/span>","<span class=\"advgb-post-tax-term\">Sage Therapeutics<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 6 years ago","modified":"Updated 1 year ago"},"absolute_dates":{"created":"Posted on Dec 16, 2019","modified":"Updated on May 8, 2025"},"absolute_dates_time":{"created":"Posted on Dec 16, 2019 3:52 pm","modified":"Updated on May 8, 2025 12:57 pm"},"featured_img_caption":"Bipolar disorder market","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/7121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=7121"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/7121\/revisions"}],"predecessor-version":[{"id":31947,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/7121\/revisions\/31947"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/7122"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=7121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=7121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=7121"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=7121"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=7121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}